Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole adjunct for Candida-associated refractory severe periodontitis
2019-003541-15Phase 4Terminated
- Sponsor
- Aarhus University
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in refractory periodontitis (RP), chronic periodontitis and periodontitis comparing Fluconazole adjunct arm with Placebo adjunct arm (2 arms). Primary endpoint: Treatment success at 3 months. Started Dec 2019; status: terminated.
02
Drugs
fluconazole
03
Conditions
refractory periodontitis (RP)chronic periodontitisperiodontitis
Beyond the preview
Go deeper on 2019-003541-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003541-15.